Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Pittsburgh
About this trial
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 or older
able and willing to provide informed consent
diagnosed with CTCL
diagnosed with either atopic dermatitis or eczema
Disqualifiers
Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
Trial population
Subjects with cutaneous t-cell lymphoma and/or Sezary syndrome and atopic dermatitis or eczema patients
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Blood draw, skin biopsy or urine collection
Other interventionUp to 9 blood draws/year of 60 ml of whole blood. One 6 mm punch biopsy may be obtained up to 4 times per year.
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: CTCL, atopic dermatitis, eczema1 intervention
Trial outcomes
Primary outcomes
1
Proteomics of Cutaneous T-cell lymphoma
Proteomic variables will be measured in blood and tissue of consented CTCL patients.
Time frame
OngoingSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov